Astrana Health (NASDAQ:ASTH - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.17), Zacks reports. The business had revenue of $654.81 million during the quarter, compared to analysts' expectations of $639.13 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.48%. The firm's quarterly revenue was up 34.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.40 EPS. Astrana Health updated its Q3 2025 guidance to EPS.
Astrana Health Stock Up 30.8%
NASDAQ ASTH traded up $6.62 during mid-day trading on Friday, reaching $28.08. 1,808,383 shares of the company's stock traded hands, compared to its average volume of 367,950. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54. The company has a fifty day simple moving average of $24.44 and a 200-day simple moving average of $29.20. Astrana Health has a 1-year low of $21.20 and a 1-year high of $63.20. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 55.06, a P/E/G ratio of 0.79 and a beta of 0.85.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Royal Bank of Canada raised its holdings in Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company's stock worth $8,640,000 after acquiring an additional 17,028 shares during the period. Intech Investment Management LLC raised its stake in shares of Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company's stock valued at $1,383,000 after buying an additional 2,462 shares in the last quarter. AQR Capital Management LLC acquired a new position in shares of Astrana Health in the 1st quarter valued at $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company's stock valued at $799,000 after buying an additional 1,263 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its holdings in shares of Astrana Health by 4,365.2% in the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company's stock worth $346,000 after purchasing an additional 10,913 shares during the last quarter. Institutional investors own 52.77% of the company's stock.
About Astrana Health
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.